Track topics on Twitter Track topics that are important to you
Imprimis Pharmaceuticals reported a net loss of $5.7 million, or $0.28 per share, in the third quarter of 2017 compared with a net loss of $3.9 million, or $0.29 per share, in the third quarter of 2016, according to a company press release.
Total revenues for the quarter increased from $4.9 million to $6.5 million, while ophthalmology-related revenue was up 60% to $4.9 million.
General and administrative costs decreased from $5 million to $4.5 million for the quarter.
Original Article: Imprimis reports $5.7 million third quarter lossNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...